1276 related articles for article (PubMed ID: 27056601)
41. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.
Kühl HP; Beek AM; van der Weerdt AP; Hofman MB; Visser CA; Lammertsma AA; Heussen N; Visser FC; van Rossum AC
J Am Coll Cardiol; 2003 Apr; 41(8):1341-8. PubMed ID: 12706930
[TBL] [Abstract][Full Text] [Related]
42. The role of quantitative Tc-99m-MIBI gated SPECT/F-18-FDG PET imaging in the monitoring of intracoronary bone marrow cell transplantation.
Kamínek M; Meluzín J; Janousek S; Groch L; Panovský R; Klabusay M; Mayer J; Prásek J; Stanícek J; Rehák Z; Myslivecek M
Nucl Med Rev Cent East Eur; 2006; 9(1):60-4. PubMed ID: 16791807
[TBL] [Abstract][Full Text] [Related]
43. Prognostic role of serial quantitative evaluation of
Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
[TBL] [Abstract][Full Text] [Related]
44. Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure.
Mielniczuk LM; Birnie D; Ziadi MC; deKemp RA; DaSilva JN; Burwash I; Tang AT; Davies RA; Haddad H; Guo A; Aung M; Williams K; Ukkonen H; Beanlands RS
Circ Cardiovasc Imaging; 2011 Jan; 4(1):59-66. PubMed ID: 21057116
[TBL] [Abstract][Full Text] [Related]
45. The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage.
Jingu K; Kaneta T; Nemoto K; Ichinose A; Oikawa M; Takai Y; Ogawa Y; Nakata E; Sakayauchi T; Takai K; Sugawara T; Narazaki K; Fukuda H; Takahashi S; Yamada S
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):845-51. PubMed ID: 17011456
[TBL] [Abstract][Full Text] [Related]
46. [Association between brain glucose metabolism and cardiac dysfunction in patients with ischemic heart disease undergoing (18)F-FDG PET/CT imaging].
Lu X; Nie BB; Yun MK; Zhu ZW; Xie XF; Mou TT; Mi HZ; Wei YX; Li X; Shan BC; Zhang XL
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Mar; 48(3):211-216. PubMed ID: 32234178
[No Abstract] [Full Text] [Related]
47. Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study.
Soares J; Rodrigues Filho F; Izaki M; Giorgi MC; Catapirra RM; Abe R; Vinagre CG; Cerri GG; Meneghetti JC
Int J Cardiovasc Imaging; 2014 Feb; 30(2):415-23. PubMed ID: 24253855
[TBL] [Abstract][Full Text] [Related]
48. [Identification of viable myocardium delayed enhancement magnetic resonance imaging and 99Tcm-sestamibi or 18F-fluorodeoxyglucose single photon emission computed tomography].
Zhao SH; Yan CW; Yang MF; Lu MJ; Jiang SL; Li SG; Zhang Y; Liu Q; Liu YQ; He ZX
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Dec; 34(12):1072-6. PubMed ID: 17274892
[TBL] [Abstract][Full Text] [Related]
49. Comparative Analysis of Myocardial Viability Multimodality Imaging in Patients with Previous Myocardial Infarction and Symptomatic Heart Failure.
Kazakauskaite E; Vajauskas D; Unikaite R; Jonauskiene I; Virbickiene A; Zaliaduonyte D; Lapinskas T; Jurkevicius R
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334543
[TBL] [Abstract][Full Text] [Related]
50. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
Hunold P; Brandt-Mainz K; Freudenberg L; Vogt FM; Neumann T; Knipp S; Barkhausen J
Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477
[TBL] [Abstract][Full Text] [Related]
51. Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability.
Roes SD; Kaandorp TA; Marsan NA; Westenberg JJ; Dibbets-Schneider P; Stokkel MP; Lamb HJ; van der Wall EE; de Roos A; Bax JJ
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):594-601. PubMed ID: 19050879
[TBL] [Abstract][Full Text] [Related]
52. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
[TBL] [Abstract][Full Text] [Related]
53. The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection.
Castellani M; Colombo A; Giordano R; Pusineri E; Canzi C; Longari V; Piccaluga E; Palatresi S; Dellavedova L; Soligo D; Rebulla P; Gerundini P
J Nucl Med; 2010 Dec; 51(12):1908-16. PubMed ID: 21078804
[TBL] [Abstract][Full Text] [Related]
54. Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging.
Xie B; Wang J; Xi XY; Guo X; Chen BX; Li L; Hua C; Zhao S; Su P; Chen M; Yang MF
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2786-2797. PubMed ID: 34984503
[TBL] [Abstract][Full Text] [Related]
55. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
Roivainen A; Parkkola R; Yli-Kerttula T; Lehikoinen P; Viljanen T; Möttönen T; Nuutila P; Minn H
Arthritis Rheum; 2003 Nov; 48(11):3077-84. PubMed ID: 14613269
[TBL] [Abstract][Full Text] [Related]
56. Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
Lapa C; Reiter T; Li X; Werner RA; Samnick S; Jahns R; Buck AK; Ertl G; Bauer WR
Int J Cardiol; 2015 Sep; 194():44-9. PubMed ID: 26005805
[TBL] [Abstract][Full Text] [Related]
57. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Irwan R; Sluiter WJ; Dierckx RA; de Boer J; Jager PL
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):716-23. PubMed ID: 16523309
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
59. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
[TBL] [Abstract][Full Text] [Related]
60. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
